Physician profile
Angela Desantis
NPI 1821376989
$1,411.26
in general payments reported to CMS, 2019-2025
15 companies · $864 in 2025
The $864 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $30.23 · 2021: $41.33 · 2022: $18.06 · 2023: $24.11 · 2024: $58.72 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $864 · Food and Beverage: $82.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $863.73 |
| Food and Beverage | $82.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $863.73 | 2025 | |
| Lupin INC. | $159.37 | 2019 | |
| Abbvie INC. | $139.63 | 2019-2021 | |
| Medtronic, INC. | $30.24 | 2024 | Ligasure |
| Therapeuticsmd, INC. | $29.55 | 2019-2020 | |
| Organon LLC | $28.48 | 2024 | |
| Allergan, INC. | $25.29 | 2019 | |
| Myriad Women'S Health, INC. | $24.11 | 2023 | |
| Evofem Biosciences, INC. | $22.92 | 2021 | |
| Meditrina | $18.06 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.50 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.51 | 2019 | |
| Duchesnay USA Incorporated | $13.19 | 2019 | |
| Exeltis, USA INC. | $13.11 | 2020 | |
| Hologic Sales and Service, LLC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Desantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.